・Lilly is reportedly shifting its 50,000 employees to Rightway, a fintech-driven pharmacy benefit manager, starting January 1. ・The move follows CVS Caremark’s decision to drop Lilly’s Zepbound from ...

Florida's Attorney General has opened an investigation into CVS Health's (NYSE:CVS) Caremark pharmacy benefit manager for ...

CVS Health is introducing a system to provide customers with greater insight into drug costs and less expensive alternatives. The plan will first be available to those using CVS' pharmacy benefit ...

This year, CVS Health plans to employ the classic "out with the old, in with the new" mantra when it comes to AbbVie’s Humira. Come April 1, the branded drug will be replaced by cheaper biosimilars ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Feb. 7, 2012 file photo, pedestrians walk past a CVS store in Chicago. Drugstore chain CVS Caremark Corp. said ...

An unsealed 2014 lawsuit by an Aetna actuary whistleblower against CVS Caremark, the insurer's pharmacy benefit manager, accuses the PBM of billing the government for prescription drugs at a greater ...

The Oklahoma Insurance Department has entered into a settlement agreement with CVS Caremark over transaction fees the pharmacy benefit manager charges pharmacists to process Medicare Part D and group ...

Caremark Rx shareholders on Friday approved a roughly $24 billion takeover offer from drug-store chain CVS bringing to an end a months-long takeover fight with Express Scripts for the rival pharmacy ...

CVS Caremark recently released its Q2 earnings and continued to post strong 16% revenue growth, benefiting from the prior Walgreen-Express Scripts impasse, new PBM client starts, specialty drug cost ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE - In this Feb. 7, 2012 file photo, pedestrians walk past a CVS store in Chicago. CVS Caremark Corp. is reporting their ...

NEW YORK — Drugstore chain operator CVS Caremark Corp. said Wednesday that it has agreed to buy the drug infusion business Coram LLC, a unit of Apria Healthcare Group, for $2.1 billion. CVS says the ...